Skip to main content

Table 2 Meta-analysis results for each outcome indicator

From: Effects of quercetin on polycystic ovary syndrome in animal models: a systematic review and meta-analysis

Outcome indicator

Heterogeneity test results

Effect models

Meta-analysis results

I2(%)

P

Effect sizes

95%CI

P

Fasting Insulin Serum Levels

94

< 0.00001

random

MD=-9.22

[-15.41, -3.02]

0.004

Fasting Blood Glucose Levels

80

0.007

random

SMD=-2.57

[-4.60, -0.55]

0.01

HOMA-IR

99

< 0.00001

random

MD=-4.13

[-5.82, -2.44]

< 0.00001

Cholesterol Levels

61

0.08

random

SMD=-6.82

[-10.21, -3.44]

< 0.0001

Triglycerides Levels

73

0.02

random

SMD=-7.33

[-11.72, -2.93]

0.001

Testosterone Levels

90

< 0.00001

random

MD=-2.02

[-2.79, -1.26]

< 0.00001

Luteinizing Hormone Levels

94

< 0.0001

random

MD=-9.23

[-14.20, -4.26]

0.0003

Luteinizing Hormone/Follicle Stimulating Hormone Ratio

98

< 0.00001

random

MD=-0.94

[-1.70, -0.19]

0.01

Vascular Endothelial Growth Factor Levels

85

0.01

random

MD=-6.69

[-9.14, -4.24]

< 0.00001

Malondialdehyde Levels

76

0.04

random

MD=-2.66

[-5.01, -0.31]

0.03

Superoxide Dismutase Levels

86

0.0006

random

SMD = 5.50

[1.27, 9.74]

0.01

The Expression of GLUT4 mRNA

49

0.16

Fixed

SMD = 7.26

[5.14, 9.38]

< 0.00001